Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines

被引:30
|
作者
Nakamura, T
Sakaeda, T
Ohmoto, N
Moriya, Y
Komoto, C
Shirakawa, T
Gotoh, A
Matsuo, M
Okumura, K [1 ]
机构
[1] Kobe Univ, Sch Med, Dept Hosp Pharm, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Sch Med, Dept Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan
[3] Kobe Univ, Sch Med, Dept Clin Genet, Chuo Ku, Kobe, Hyogo 6500017, Japan
[4] Kobe Univ, Sch Med, Int Ctr Med Res, Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
MDR1; multidrug resistance-associated protein (MRP); villin; in vitro screening model;
D O I
10.1023/A:1022251910820
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The mRNA levels of MDR1 (P-glycoprotein), multidrug resistance-associated proteins (MRP1, MRP2), cytochrome P450 3A (CYP3A) and villin in human colorectal cell lines (HCT-15, LoVo, DLD-1, HCT-116 and SW620) were quantitatively compared with those in Caco-2 cells. Methods. The mRNA levels were determined by real time quantitative polymerase chain reaction and expressed as the relative concentrations of MDR1 mRNA to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Results. MDR1 mRNA was expressed in HCT-15 LoVo and DLD-1 cells at similar or lower level to Caco-2. The expression of MRP1 mRNA in the cell lines tested was comparable with Caco-2. MRP2 mRNA was detected only in HCT-116 and SW620 at significantly lower level than Caco-2. CYP3A mRNA was detected in HCT-15, LoVo, DLD-1 and SW620 at similar level to Caco-2. Conclusions. HCT-15 LoVo and DLD-1 cells express proteins important for regulating the intestinal absorption of drugs, i.e., MDR1, MRP1 and CYP3A, whereas HCT-116 and SW620 cells were not acceptable for evaluation of absorption properties of drug candidates.
引用
收藏
页码:324 / 327
页数:4
相关论文
共 50 条
  • [21] Genetically Modified Caco-2 Cells With Improved Cytochrome P450 Metabolic Capacity
    Kublbeck, Jenni
    Hakkarainen, Jenni J.
    Petsalo, Aleksanteri
    Vellonen, Kati-Sisko
    Tolonen, Ari
    Reponen, Petri
    Forsberg, Markus M.
    Honkakoski, Paavo
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (02) : 941 - 949
  • [22] Characterization of THLE-Cytochrome P450 (P450) Cell Lines: Gene Expression Background and Relationship to P450-Enzyme Activity
    Soltanpour, Yalda
    Hilgendorf, Constanze
    Ahlstrom, Marie M.
    Foster, Alison J.
    Kenna, J. Gerry
    Petersen, Anne
    Ungell, Anna-Lena
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (11) : 2054 - 2058
  • [23] The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons
    Finta, C
    Zaphiropoulos, PG
    GENE, 2000, 260 (1-2) : 13 - 23
  • [24] EXPRESSION OF CYTOCHROME-P-450 3A IN HT29-MTX CELLS AND CACO-2 CLONE TC7
    CARRIERE, V
    LESUFFLEUR, T
    BARBAT, A
    ROUSSET, M
    DUSSAULX, E
    COSTET, P
    DEWAZIERS, I
    BEAUNE, P
    ZWEIBAUM, A
    FEBS LETTERS, 1994, 355 (03) : 247 - 250
  • [25] A MICROTITER-PLATE-BASED CYTOCHROME P450 3A ACTIVITY ASSAY IN FISH CELL LINES
    Christen, Verena
    Oggier, Daniela M.
    Fent, Karl
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2009, 28 (12) : 2632 - 2638
  • [26] The effect of lycopene on cytochrome P450 isoenzymes and P-glycoprotein by using human liver microsomes and Caco-2 cell monolayer model
    Kong, Lingti
    Song, Chunli
    Ye, Linhu
    Xu, Jian
    Guo, Daohua
    Shi, Qingping
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2018, 69 (07) : 835 - 841
  • [27] Cytochrome P450 genes expression in human prostate cancer
    Maksymchuk, Oksana
    Gerashchenko, Ganna
    Rosohatska, Inna
    Kononenko, Oleksiy
    Tymoshenko, Andriy
    Stakhovsky, Eduard
    Kashuba, Volodymyr
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2024, 38
  • [28] New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology
    Stevens, Jeffrey C.
    DRUG DISCOVERY TODAY, 2006, 11 (9-10) : 440 - 445
  • [29] Cytochrome P450 CYP3A in human renal cell cancer
    G I Murray
    M C E McFadyen
    R T Mitchell
    Y-L Cheung
    A C Kerr
    W T Melvin
    British Journal of Cancer, 1999, 79 : 1836 - 1842
  • [30] Role of transgene expression on hepatic cytochrome P450 3A and 2C11
    Callahan, SM
    Lu, SK
    Ming, X
    Brunner, LJ
    Croyle, MA
    MOLECULAR THERAPY, 2003, 7 (05) : S58 - S58